Possible benefits of the targeting of indoleamine 2,3-dioxygenase (IDO) in hepatitis B vaccination

被引：2
|
作者：
Straten, Per Thor [1 ]
Andersen, Mads Hald [1 ]
机构：
[1] Copenhagen Univ Hosp, Dept Hematol, Ctr Canc Immune Therapy CCIT, DK-2730 Herlev, Denmark
来源：
VACCINE | 2011年 / 29卷 / 21期
关键词：
IDO; Vaccination; Hepatitis B;
D O I：
10.1016/j.vaccine.2011.03.007
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3728 / 3728
页数：1
相关论文
共 50 条
  • [1] Indoleamine 2,3-Dioxygenase (IDO) silencing for improved antitumour vaccination
    Macagno, M.
    Bolli, E.
    Marchini, C.
    Amici, A.
    Riganti, C.
    Bosia, A.
    Forni, G.
    Cavallo, F.
    EJC SUPPLEMENTS, 2010, 8 (05): : 75 - 75
  • [2] Indoleamine 2,3-dioxygenase vaccination
    Andersen, Mads Hald
    Svane, Inge Marie
    ONCOIMMUNOLOGY, 2015, 4 (01) : 983770
  • [3] Synthesis of indoleamine 2,3-dioxygenase (IDO) inhibitor
    Suzuki, Takafumi
    Yokoyama, Yuuaku
    Tsutumi, Katsuhiko
    Yamaguchi, Tomoyuki
    Takikawa, Osamu
    Okuno, Hiroaki
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 62 (01) : 114 - 115
  • [4] The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
    von Bubnoff, D.
    Bieber, T.
    ALLERGY, 2012, 67 (06) : 718 - 725
  • [5] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [6] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [7] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [8] Targeting the indoleamine 2,3-dioxygenase pathway in cancer
    Moon, Yong Wha
    Hajjar, Joud
    Hwu, Patrick
    Naing, Aung
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
  • [9] Indoleamine 2,3-Dioxygenase (Ido) As A New Immunological Marker In Kidney
    Loiacono, Elisa
    Votta, Barbara
    Amore, Alessandro
    Peruzzi, Licia
    Puccinelli, Maria Paola
    Camilla, Roberta
    Vergano, Luca
    Guido, Giuliana
    Donadi, Maria Elena
    Coppo, Rosanna
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1525 - 1526
  • [10] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
12345